TABLE 2.
C57BL/6N | DBA/2 | FVB/N | C57BL/6N | DBA/2 | FVB/N | |
|
|
|||||
P22–26 cohort | P32–36 cohort | |||||
Tail suspension test: Immobility duration | 0.979 | 0.087 | >0.999 | 0.160 | >0.999 | >0.999 |
Tail suspension test: Latency to immobility | >0.999 | 0.470 | >0.999 | >0.999 | >0.999 | 0.321 |
Sucrose preference index | >0.999 | >0.999 | >0.999 | >0.999 | >0.999 | >0.999 |
Forced swim test: Immobility duration | 0.117 | 0.422 | >0.999 | 0.401 | >0.999 | >0.999 |
Forced swim test: Latency to immobility | 0.243 | >0.999 | >0.999 | >0.999 | >0.999 | >0.999 |
Forced swim test: Total traveled distance | >0.999 | >0.999 | >0.999 | 0.581 | 0.996 | >0.999 |
P27 cohort | P37 cohort | |||||
Hyponeophagia test trial 1: Latency to drink | 0.006 | 0.041 | >0.999 | >0.999 | >0.999 | >0.999 |
Hyponeophagia test trial 2: Latency to drink | 0.014 | 0.027 | 0.550 | >0.999 | 0.721 | >0.999 |
The italic indicates significant results.